Total Payments
$3,568
2024 Payments
$487.85
Companies
31
Transactions
205
Medicare Patients
3,036
Medicare Billing
$251,719
Payment Breakdown by Category
Food & Beverage$3,228 (90.5%)
Education$339.62 (9.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,228 | 201 | 90.5% |
| Education | $339.62 | 4 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $675.77 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $651.02 | 57 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $399.15 | 27 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $320.47 | 15 | $0 (2024) |
| Cogentix Medical Inc. | $192.09 | 3 | $0 (2017) |
| Myovant Sciences Inc. | $140.55 | 6 | $0 (2022) |
| PFIZER INC. | $138.74 | 8 | $0 (2023) |
| UROVANT SCIENCES INC | $125.36 | 7 | $0 (2022) |
| Amgen Inc. | $99.42 | 7 | $0 (2020) |
| Teleflex LLC | $98.13 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $487.85 | 22 | Sumitomo Pharma America, Inc. ($167.15) |
| 2023 | $361.72 | 18 | Sumitomo Pharma America, Inc. ($153.32) |
| 2022 | $723.11 | 35 | Janssen Biotech, Inc. ($209.87) |
| 2021 | $253.19 | 14 | Janssen Biotech, Inc. ($68.78) |
| 2020 | $144.32 | 10 | Astellas Pharma US Inc ($43.33) |
| 2019 | $470.87 | 32 | Astellas Pharma US Inc ($193.54) |
| 2018 | $612.81 | 45 | Endo Pharmaceuticals Inc. ($181.90) |
| 2017 | $513.73 | 29 | Cogentix Medical Inc. ($192.09) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: HORMONE THERAPY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Wound Closure | ||||||
| 10/09/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $36.18 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: HORMONE THERAPY | ||||||
| 07/03/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: HORMONE THERAPY | ||||||
| 04/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: UROLOGY | ||||||
| 03/27/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: UROLOGY | ||||||
| 03/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: UROLOGY | ||||||
| 02/21/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: UROLOGY | ||||||
| 02/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: HORMONE THERAPY | ||||||
| 01/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/19/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: HORMONE THERAPY | ||||||
| 01/17/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: UROLOGY | ||||||
| 11/29/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: HORMONE THERAPY | ||||||
| 11/01/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/26/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: OVER ACTIVE BLADDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 467 | 622 | $167,436 | $41,033 |
| 2022 | 10 | 530 | 734 | $219,656 | $46,592 |
| 2021 | 15 | 819 | 1,114 | $270,944 | $69,279 |
| 2020 | 26 | 1,220 | 3,064 | $375,065 | $94,816 |
Total Patients
3,036
Total Services
5,534
Medicare Billing
$251,719
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 180 | $46,692 | $15,407 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 209 | $36,525 | $12,377 | 33.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 35 | 40 | $29,000 | $6,784 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $19,750 | $4,843 | 24.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 92 | 118 | $9,208 | $798.66 | 8.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 11 | 11 | $4,211 | $569.30 | 13.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 13 | 14 | $22,050 | $254.22 | 1.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 179 | 279 | $48,775 | $17,447 | 35.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 39 | 51 | $36,975 | $9,113 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 114 | $29,604 | $8,767 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $26,465 | $7,225 | 27.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 13 | $20,663 | $1,173 | 5.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 15 | 16 | $6,320 | $944.16 | 14.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 85 | 125 | $9,337 | $824.26 | 8.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 20 | 25 | $37,851 | $480.94 | 1.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 17 | 30 | $1,950 | $474.66 | 24.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 14 | $1,716 | $143.31 | 8.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 216 | $53,316 | $18,703 | 35.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 103 | 103 | $40,410 | $12,438 | 30.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 13 | 75 | $62,619 | $11,483 | 18.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 144 | 188 | $31,575 | $11,440 | 36.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 31 | 40 | $29,225 | $7,171 | 24.5% |
| 64566 | Implantation of lower leg neurostimulator electrode, accessed through the skin | Office | 2021 | 20 | 50 | $12,500 | $4,427 | 35.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 98 | 134 | $7,402 | $966.51 | 13.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 16 | $1,666 | $652.20 | 39.1% |
About Dr. Patrick Mckenzie, MD
Dr. Patrick Mckenzie, MD is a Urology healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1225359920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Mckenzie, MD has received a total of $3,568 in payments from pharmaceutical and medical device companies, with $487.85 received in 2024. These payments were reported across 205 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,228).
As a Medicare-enrolled provider, Mckenzie has provided services to 3,036 Medicare beneficiaries, totaling 5,534 services with total Medicare billing of $251,719. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Greensboro, NC
- Active Since 06/16/2010
- Last Updated 03/17/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225359920
Products in Payments
- ORGOVYX (Drug) $375.55
- XIAFLEX (Biological) $312.93
- XTANDI (Drug) $268.94
- MYRBETRIQ (Drug) $248.23
- ERLEADA (Drug) $248.11
- GEMTESA (Drug) $210.83
- Urgent PC (Device) $192.09
- ZYTIGA (Drug) $173.87
- Myrbetriq (Drug) $157.97
- Erleada (Drug) $116.25
- Prolia (Biological) $85.05
- KEYTRUDA (Biological) $76.87
- AVEED (Biological) $72.97
- BOTOX (Biological) $72.16
- ELIGARD (Drug) $66.95
- Nubeqa (Drug) $64.24
- UroLift System (Device) $62.11
- REZUM (Device) $59.52
- PROVENGE (Drug) $58.56
- INTERSTIM (Device) $50.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Greensboro
Scott Macdiarmid, Md, MD
Urology — Payments: $1.1M
Urology $1.1M
Dr. Matthew Eskridge, Md, MD
Urology — Payments: $7,158
Urology $7,158
John Wrenn, Md, MD
Urology — Payments: $6,665
Urology $6,665
Stephen Dahlstedt, Md, MD
Urology — Payments: $5,818
Urology $5,818
Dr. Benjamin Herrick, M.d, M.D
Urology — Payments: $4,794
Urology $4,794
Dr. Theodore Manny, M.d, M.D
Urology — Payments: $4,272
Urology $4,272